Leonard Farber

New York City, New York

Leonard Farber

New York City, New York

A Board Certified physician in Radiation Oncology, Dr. Farber has been in private practice for over a decade and a half. In academia, he has recently served as Chairman of Radiation Oncology at Staten Island University Hospital where he focused on introducing state-of-the-art techniques.

Dr. Farber specializes in adult radiation oncology, with particular focus on cancers of the prostate, breast, lung, skin, and gastrointestinal and gynecologic malignancies. He has special interest in the most sophisticated therapies, including HDR brachytherapy for various types of cancers, including breast, skin, and gynecologic malignancies, and intracranial and stereotactic body radiation therapy (SBRT). He has implemented volumetric arc therapy (VMAT) in the treatment of benign parotid enlargement/hypertrophy, a disfiguring condition effecting a variety of patients, especially the HIV+ community.

After receiving his B.S. and B.A. at the State University of New York at Binghamton, Dr. Farber pursued his M.D. at the Mt. Sinai School of Medicine in New York. Following an internship in internal medicine at Beth Israel Medical Center in New York, he completed a residency in Radiation Oncology at the Hospital of the University of Pennsylvania in Philadelphia, where he served as Chief Resident. Dr. Farber is a member of the American Society for Therapeutic Radiology and Oncology, the American College of Radiation Oncology, the NY Roentgen Society, the American Brachytherapy Society, the American Medical Society, the International Society of Gastrointestinal Oncology, the New York Cancer Society, the New York Metropolitan Breast Cancer Group, the New York Head & Neck Society, and several others.

Dr. Farber’s published writings and lectures have focused on HDR brachytherapy, pancreatic and bile duct cancers, head and neck cancer, breast cancer, Positron Emission Therapy (PET), and cardiovascular radiation. He has served as principal investigator on many clinical trials and has been on the forefront of the HDR treatment for various types of malignant and benign conditions and SBRT for various malignancies and sites.

  • Work
    • The Farber Center for Radiation Oncology
  • Education
    • M.D.